Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis

Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis

Background: Limited data on the efficacy and safety of currently applied COVID-19 therapeutics and their impact on COVID-19 outcomes have raised additional concern.Objective and Methods: To estimate the efficacy and safety of COVID-19 therapeutics, we performed meta-analyses of the studies reporting...

Full description

Bibliographic Details
Main Authors:	Zeinab Abdelrahman, Qian Liu, Shanmei Jiang, Mengyuan Li, Qingrong Sun, Yue Zhang, Xiaosheng Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Pharmacology
Subjects:	COVID-19 treatment meta-analysis antiviral agents hydroxychloroquine dexamethasone remdesivir
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.607408/full

Similar Items

A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management
by: Muhammad Harris Shoaib, et al.
Published: (2021-02-01)

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
by: Abubakar AR, et al.
Published: (2020-12-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents
by: Shagun B Shah, et al.
Published: (2021-01-01)

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
by: Safaet Alam, et al.
Published: (2021-06-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
by: Muhammad Haroon Aftab, et al.
Published: (2024-01-01)

Remdesivir in a pregnant patient with COVID-19 pneumonia
by: Ranadheer Dande, et al.
Published: (2021-01-01)

A study to assess the outcome in COVID-19 confirmed cases receiving Remdesivir as compared to conventional therapy: Medical records-based audit
by: Divya Prabhu, et al.
Published: (2022-01-01)

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
by: Sultan Ayoub Meo, et al.
Published: (2020-10-01)

Cell cycle activity correlates with increased anti‐tumor immunity in diverse cancers
by: Shanmei Jiang, et al.
Published: (2020-06-01)

Correction to: The Cancer Omics Atlas: an integrative resource for cancer omics annotations
by: Qingrong Sun, et al.
Published: (2018-08-01)

The Cancer Omics Atlas: an integrative resource for cancer omics annotations
by: Qingrong Sun, et al.
Published: (2018-08-01)

Investigational medications in 9,638 hospitalized patients with severe COVID-19: lessons from the “fail-and-learn” strategy during the first two waves of the pandemic in 2020
by: Adam C. Delgado, et al.
Published: (2023-04-01)

The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration’s Adverse Event Reporting System
by: Deemah S. Alsuhaibani, et al.
Published: (2023-07-01)

A Mini Review : Clinically Significant Potential Drug-Drug Interactions In COVID-19 and Comorbid Therapy
by: Ana Khusnul Faizah, et al.
Published: (2020-07-01)

Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis
by: Todd C. Lee, et al.
Published: (2021-03-01)

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)
by: Abhi Bhadra, et al.
Published: (2020-05-01)

COVID-19: An Update about the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-05-01)

COVID-19: A Brief Overview of the Discovery Clinical Trial
by: Jean Jacques Vanden Eynde
Published: (2020-04-01)

Doxycycline as a potential partner of COVID-19 therapies
by: Alexandre E. Malek, et al.
Published: (2020-01-01)

A narrative review of antiviral drugs used for COVID-19 pharmacotherapy
by: Subodh Kumar, et al.
Published: (2021-01-01)

Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia
by: Daniel A. Placik, MD, et al.
Published: (2020-11-01)

The perfect storm: A case of COVID-19 infection in an adolescent patient with EVALI
by: Kubra Melike Bozkanat, et al.
Published: (2020-01-01)

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
by: Cristina Adriana Dehelean, et al.
Published: (2020-07-01)

Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis
by: Pallavi Dubey, et al.
Published: (2021-03-01)

Scoping insight on antiviral drugs against COVID-19
by: Ahmed S. Ali, et al.
Published: (2021-10-01)

A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking
by: Achal Mishra, et al.
Published: (2021-06-01)

Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan
by: Yi-Hsuan Lai, et al.
Published: (2023-12-01)

Evaluation of the efficacy and safety of oral N‐acetylcysteine in patients with COVID‐19 receiving the routine antiviral and hydroxychloroquine protocol: A randomized controlled clinical trial
by: Najmolsadat Atefi, et al.
Published: (2023-11-01)

COVID-19 treatment in children: A systematic review and meta-analysis
by: Prateek Kumar Panda, et al.
Published: (2021-01-01)

Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
by: Milo Gatti, et al.
Published: (2021-02-01)

Experimental therapies under investigation for COVID-19
by: Reshma Golamari, et al.
Published: (2021-03-01)

Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
by: David Grimaldi, et al.
Published: (2020-10-01)

Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences
by: Y. Roussel, et al.
Published: (2020-11-01)

Clinical characteristics and courses of 200 patients hospitalized for COVID-19 during the second and third waves at Fujita Health University Okazaki Medical Center in Japan
by: Masamichi Hayashi, et al.
Published: (2023-02-01)

Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literature
by: Davide Marangoni, et al.
Published: (2023-08-01)

Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
by: Seong Joon Ahn, et al.
Published: (2018-12-01)

Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
by: Paul Andrei Negru, et al.
Published: (2022-03-01)

COVID-19 possible medical treatments
by: Marzieh Mohammadi, et al.
Published: (2021-01-01)

Treatment Options for COVID-19: A Review
by: Mukarram Jamat Ali, et al.
Published: (2020-07-01)